Moreover, we showed that IGFBP7 serum levels at baseline can predict new onset liver fibrosis over time, defined as ELF ≥ 9.8 at follow‐up in participants with ELF < 9.8 at baseline, with good diagnostic accuracy (AUC 0.79). Here, IGFBP7 is linked to Hepatic fibrosis.